Passage BIO PASG
NASDAQ PASG
$4.44 -0.04 (-0.89%)
At close: Aug 21, 2026 · 4:00 PM EDT

Passage BIO (PASG) Change in Acquisitions & Divestments (2021 - 2025)

Passage BIO (PASG) posted quarterly Change in Acquisitions & Divestments of $39.0 million for Q1 2025, little changed year-over-year from $39.1 million in Q1 2024, and up 33.41% quarter-over-quarter from $29.3 million in Q4 2024.

Passage BIO (PASG) Change in Acquisitions & Divestments (2021 - 2025) Analysis & Trends

Passage BIO's Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $39.0 million for Q1 2025.

  • In Q1 2025, Change in Acquisitions & Divestments changed 0.04% year-over-year to $39.0 million; the TTM figure through Dec 2025 stood at $39.0 million (down 72.72% YoY), while the FY2025 annual figure was $39.0 million, down 72.72% from the prior year.
  • Change in Acquisitions & Divestments for Q1 2025 stood at $39.0 million, up from $29.3 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $72.6 million in Q1 2023, with the low at $29.3 million in Q4 2024.
  • The 5-year median for Change in Acquisitions & Divestments is $38.6 million (2022), against an average of $44.0 million.
  • The sharpest annual moves came in 2022 and 2024: Change in Acquisitions & Divestments soared 44.46% in 2022, then tumbled 46.23% in 2024.
  • Passage BIO's Change in Acquisitions & Divestments stood at $36.4 million in 2021, then increased by 6.17% to $38.6 million in 2022, then slipped by 8.39% to $35.4 million in 2023, then declined by 17.33% to $29.3 million in 2024, then soared by 33.41% to $39.0 million in 2025.
  • Business Quant data shows PASG's Change in Acquisitions & Divestments at $39.0 million in Q1 2025, $29.3 million in Q4 2024, and $36.8 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Passage BIO 13.99 Mn 13.99 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 39.05 Mn
Mar 31, 2025 39.05 Mn
Dec 31, 2024 29.27 Mn
Dec 31, 2024 29.27 Mn
Sep 30, 2024 36.76 Mn
Sep 30, 2024 36.76 Mn
Jun 30, 2024 38.06 Mn
Jun 30, 2024 38.06 Mn
Mar 31, 2024 39.06 Mn
Mar 31, 2024 39.06 Mn
Dec 31, 2023 35.41 Mn
Dec 31, 2023 35.41 Mn
Sep 30, 2023 50.57 Mn
Sep 30, 2023 50.57 Mn
Jun 30, 2023 36.20 Mn
Jun 30, 2023 36.20 Mn
Mar 31, 2023 72.64 Mn
Mar 31, 2023 72.64 Mn
Dec 31, 2022 38.65 Mn
Dec 31, 2022 38.65 Mn